These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 22958921)

  • 21. Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding.
    Markan KR; Naber MC; Ameka MK; Anderegg MD; Mangelsdorf DJ; Kliewer SA; Mohammadi M; Potthoff MJ
    Diabetes; 2014 Dec; 63(12):4057-63. PubMed ID: 25008183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FGF21 Signals Protein Status to the Brain and Adaptively Regulates Food Choice and Metabolism.
    Hill CM; Laeger T; Dehner M; Albarado DC; Clarke B; Wanders D; Burke SJ; Collier JJ; Qualls-Creekmore E; Solon-Biet SM; Simpson SJ; Berthoud HR; Münzberg H; Morrison CD
    Cell Rep; 2019 Jun; 27(10):2934-2947.e3. PubMed ID: 31167139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin is essential for optimal cell signaling by FGF21 and for regulation of βKlotho cellular stability.
    An SJ; Mohanty J; Tome F; Suzuki Y; Lax I; Schlessinger J
    Proc Natl Acad Sci U S A; 2023 Feb; 120(7):e2219128120. PubMed ID: 36745784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice.
    Gong Q; Hu Z; Zhang F; Cui A; Chen X; Jiang H; Gao J; Chen X; Han Y; Liang Q; Ye D; Shi L; Chin YE; Wang Y; Xiao H; Guo F; Liu Y; Zang M; Xu A; Li Y
    Hepatology; 2016 Aug; 64(2):425-38. PubMed ID: 26926384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hepatokine FGF21 is crucial for peroxisome proliferator-activated receptor-α agonist-induced amelioration of metabolic disorders in obese mice.
    Goto T; Hirata M; Aoki Y; Iwase M; Takahashi H; Kim M; Li Y; Jheng HF; Nomura W; Takahashi N; Kim CS; Yu R; Seno S; Matsuda H; Aizawa-Abe M; Ebihara K; Itoh N; Kawada T
    J Biol Chem; 2017 Jun; 292(22):9175-9190. PubMed ID: 28404815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of β-Klotho in Adipose Tissue Sensitizes Male Mice to Endogenous FGF21 and Provides Protection From Diet-Induced Obesity.
    Samms RJ; Cheng CC; Kharitonenkov A; Gimeno RE; Adams AC
    Endocrinology; 2016 Apr; 157(4):1467-80. PubMed ID: 26901091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibroblast growth factor-21, energy balance and obesity.
    Giralt M; Gavaldà-Navarro A; Villarroya F
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():66-73. PubMed ID: 26415590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FGF21 regulates metabolism and circadian behavior by acting on the nervous system.
    Bookout AL; de Groot MH; Owen BM; Lee S; Gautron L; Lawrence HL; Ding X; Elmquist JK; Takahashi JS; Mangelsdorf DJ; Kliewer SA
    Nat Med; 2013 Sep; 19(9):1147-52. PubMed ID: 23933984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB.
    Yang C; Jin C; Li X; Wang F; McKeehan WL; Luo Y
    PLoS One; 2012; 7(3):e33870. PubMed ID: 22442730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
    Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
    J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FGF21 contributes to neuroendocrine control of female reproduction.
    Owen BM; Bookout AL; Ding X; Lin VY; Atkin SD; Gautron L; Kliewer SA; Mangelsdorf DJ
    Nat Med; 2013 Sep; 19(9):1153-6. PubMed ID: 23933983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat.
    Li H; Wu G; Fang Q; Zhang M; Hui X; Sheng B; Wu L; Bao Y; Li P; Xu A; Jia W
    Nat Commun; 2018 Jan; 9(1):272. PubMed ID: 29348470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrasound‑targeted microbubble destruction technology delivering β‑klotho to the heart enhances FGF21 sensitivity and attenuates heart remodeling post‑myocardial infarction.
    Yue C; Li R; Li C; Yang T; Huang X; Lei R; Yan Y; Liu Y; Li Q; Yan Q; Zuo D; Liu S; Yang M
    Int J Mol Med; 2024 Jun; 53(6):. PubMed ID: 38666537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interplay between FGF21 and insulin action in the liver regulates metabolism.
    Emanuelli B; Vienberg SG; Smyth G; Cheng C; Stanford KI; Arumugam M; Michael MD; Adams AC; Kharitonenkov A; Kahn CR
    J Clin Invest; 2014 Feb; 124(2):515-27. PubMed ID: 24401271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21.
    Owen BM; Mangelsdorf DJ; Kliewer SA
    Trends Endocrinol Metab; 2015 Jan; 26(1):22-9. PubMed ID: 25476453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole-body and adipose tissue-specific mechanisms underlying the metabolic effects of fibroblast growth factor 21 in the Siberian hamster.
    Lewis JE; Monnier C; Marshall H; Fowler M; Green R; Cooper S; Chiotellis A; Luckett J; Perkins AC; Coskun T; Adams AC; Samms RJ; Ebling FJP; Tsintzas K
    Mol Metab; 2020 Jan; 31():45-54. PubMed ID: 31918921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FGF21 in obesity and cancer: New insights.
    Lu W; Li X; Luo Y
    Cancer Lett; 2021 Feb; 499():5-13. PubMed ID: 33264641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different roles of N- and C- termini in the functional activity of FGF21.
    Micanovic R; Raches DW; Dunbar JD; Driver DA; Bina HA; Dickinson CD; Kharitonenkov A
    J Cell Physiol; 2009 May; 219(2):227-34. PubMed ID: 19117008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.
    Gallego-Escuredo JM; Gómez-Ambrosi J; Catalan V; Domingo P; Giralt M; Frühbeck G; Villarroya F
    Int J Obes (Lond); 2015 Jan; 39(1):121-9. PubMed ID: 24813368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21.
    Camporez JP; Asrih M; Zhang D; Kahn M; Samuel VT; Jurczak MJ; Jornayvaz FR
    J Endocrinol; 2015 Sep; 226(3):207-17. PubMed ID: 26203166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.